An in vitro comparison of the antimicrobial activity of honey, iodine and silver wound dressings

Bioscience Horizons

Volumn 4, Issue 1, 2011, Pages 61-70

  Bradshaw, Claire E ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Antimicrobial; Chronic wound; Honey; Iodine; Silver; Wound dressing

Indexed keywords

EID: 84862639324     PISSN: None     EISSN: 17547431     Source Type: Journal    
DOI: 10.1093/biohorizons/hzr008     Document Type: Article

References (45)

1. Benbow M (2005) Wound management. Evidence-based Wound Management. London: Whurr Publishers Ltd. pp. 19-31, 95-180.
2. Dealey C, Cameron J (2008) Wound Management. Chichester: Wiley-Blackwell.
3. Clark RF, Ghosh K, Tonnesen MG (2007) Tissue engineering for cutaneous wounds. J Invest Dermatol 127: 1018-1029. (Pubitemid 46625159)
4. O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG (2010) Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 1: CD003557.
5. Leaper DJ (2006) Silver dressings: their role in wound management. Int Wound J 3: 282-294.
6. Thorn RM, Greenman J, Austin A (2006) An in vitro study of antimicrobial activity and efficacy of iodine-generating hydrogel dressings. J Wound Care 15: 305-10.
7. Fong J, Wood F (2006) Nanocrystalline silver dressings in wound management: a review. Int J Nanomed 1: 441-449.
8. Nelson EA, O'Meara S, Golder S, Dalton J, Craig D, Iglesias C (2006) Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 23: 348-359.
9. Fisher TK, Wolcott R, Wolk DM, Bharara M, Kimbriel HR, Armstrong DG (2010) Diabetic foot infections: a need for innovative assessments. Int J Low Extrem Wounds 9: 31-36.
10. Thorn RM, Austin AJ, Greenman J, Wilkins JP, Davis PJ (2009) In vitro comparison of antimicrobial activity of iodine and silver dressings against biofilms. J Wound Care 18: 343-346.
11. BNF (2008) Wound management products. British National Formulary, 56th ed. London: BMJ Group &RPS Publishing, pp 867-884.
12. Thomas S, McCubbin P (2003) An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care 12: 305-308.
13. Michaels JA, Campbell WB, King BM et al. (2009) A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial. Health Technol Assess 13: 1, 114, iii.
14. Simon A, Traynor K, Santos K, Blaser G, Bode U, Molan P (2009) Medical honey for wound care-still the 'latest resort'? Evid Based Complement Alternat Med 6: 165-173.
15. Moore OA, Smith LA, Campbell F, Seers K, McQuay HJ, Moore RA (2001) Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med 1: 2.
16. Du Toit DF, Page BJ (2009) An in vitro evaluation of the cell toxicity of honey and silver dressings. J Wound Care 18: 383-389.
17. Jull A, Walker N, Parag V, Molan P, Rodgers A (2008) Honey as Adjuvant Leg Ulcer Therapy trial collaborators. Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 95: 175-182.
18. Mullai V, Menon T (2007) Bactericidal activity of different types of honey against clinical and environmental isolates of pseudomonas aeruginosa. J Altern Complement Med 13: 439-441. (Pubitemid 46802349)
19. French VM, Cooper RA, Molan PC (2005) The antibacterial activity of honey against coagulase-negative staphylococci. J Antimicrob Chemother 56: 228-231. (Pubitemid 41418363)
20. Olaitan PB, Adeleke OE, Ola IO (2007) Honey: a reservoir for microorganisms and an inhibitory agent for microbes. Afr Health Sci 7: 159-165.
21. Leaper DJ, Durani P (2008) Topical antimicrobial therapy of chronic wounds healing by secondary intention using iodine products. Int Wound J 5: 361-368. (Pubitemid 351731664)
22. McDonnell G, Russell AD (1999) Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12: 147-179. (Pubitemid 29055958)
23. Thomas S, McCubbin P (2003) A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 12: 101-107.
24. Burd A, Kwok CH, Hung SC et al. (2007) A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 15: 94-104. (Pubitemid 46146668)
25. Asavavisithchai S, Oonpraderm A, Ruktanonchai UR (2009) The antimicrobial effect of open-cell silver foams. J Mater Sci Mater Med 21: 1329-1334.
26. Maple PA, Hamilton-Miller JM, Brumfitt W (1992) Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 29: 661-668.
27. Jones SA, Bowler PG, Walker M, Parsons D (2004) Controlling wound bioburden with a novel silver-containing hydrofiber dressing. Wound Repair Regen 12: 288-294. (Pubitemid 38880437)
28. Loh JV, Percival SL, Woods EJ, Williams NJ, Cochrane CA (2009) Silver resistance in MRSA isolated from wound and nasal sources in humans and animals. Int Wound J 6: 32-38.
29. Parsons D, Bowler PG, Myles V, Jones S (2005) Silver antimicrobial dressings in wound management: a comparison of antibacterial, physical, and chemical characteristics. Wounds 17: 222-232. (Pubitemid 41305917)
30. Cooper RA, Molan PC, Harding KG (1999) Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. J R Soc Med 92: 283-285. (Pubitemid 29312959)
31. Cooper RA, Molan PC, Harding KG (2002) The sensitivity to honey of grampositive cocci of clinical significance isolated from wounds. J Appl Microbiol 93: 857-863. (Pubitemid 35340889)
32. Cooper RA, Halas E, Molan PC (2002) The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil 23: 366-370. (Pubitemid 35453583)
33. Iodozyme &oxyzyme [homepage on the Internet]: Archimed (2009) Available from: http://www.archimed.co.uk.
34. Smith &Nephew (2001) Iodoflex dressing [homepage on the Internet]. Available from: http://wound.smith-nephew.com/UK.
35. Prager EM, Gardner RE (1979) Iatrogenic hypothyroidism from topical iodine-containing medications. West J Med 130: 553-555. (Pubitemid 9231116)
36. Van den Broek PJ, Buys LF, Van Furth R (1982) Interaction of povidone-iodine compounds, phagocytic cells, and microorganisms. Antimicrob Agents Chemother 22: 593-597. (Pubitemid 13206537)
37. Balin AK, Pratt L (2002) Dilute povidone-iodine solutions inhibit human skin fibroblast growth. Dermatol Surg 28: 210-214. (Pubitemid 34259745)
38. Zhou LH, Nahm WK, Badiavas E, Yufit T, Falanga V (2002) Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br J Dermatol 146: 365-374. (Pubitemid 34603807)
39. Zeitlinger MA, Sauermann R, Traunmuller F, Georgopoulos A, Muller M, Joukhadar C (2004) Impact of plasma protein binding on antimicrobial activity using time-killing curves. J Antimicrob Chemother 54: 876-880. (Pubitemid 39529981)
40. Barrett S (2009) Mepilex ag: an antimicrobial, absorbent foam dressing with safetac technology. Br J Nurs 18: S28, S30-S36.
41. ACTISORBTM silver 220 [homepage on the Internet]: Systagenix Wound Management (2010) (updated 27 January 2010). Available from: http:// www.systagenix.co.uk/our-products/actisorb/.
42. Qin Y (2005) Silver-containing alginate fibres and dressings. Int Wound J 2: 172-176.
43. Lansdown AB (2004) A review of the use of silver in wound care: facts and fallacies. Br J Nurs 13(6 Suppl): S6-S19.
44. Khan JA, Iqbal Z, Rahman SU, Farzana K, Khan A (2008) Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics. Pak J Pharm Sci 21: 311-315.
45. Cutting K, White R, Hoekstra H (2009) Topical silver-impregnated dressings and the importance of the dressing technology. Int Wound J 6: 396-402.